The COVID-19 Treatment Landscape: A South African Perspective on a Race Against Time
Medicine
[키워드] “cytokine storm”
acute respiratory distress
affected
African
Against
Antimalarials
antivirals
ARDS
benefit
cause
caused
changed
clinical benefit
clinical trials
COVID-19
CRS
Cytokine release syndrome
Dexamethasone
disease
dosage
drug
Effect
greater
greatest number
healthcare
HFNC
High flow nasal oxygen
high mortality rate
identify
implementation
invasive ventilation
Local
multi-organ dysfunction
nasal
NIV
non-invasive ventilation
oxygen
pandemic
Patient
patients
race
randomized trial
receiving
reflect
report
required
resource
SARS-CoV-2
shown
South
South Africa
standardized protocols
syndrome
Thrombotic complications
time
tissue damage
Tocilizumab
Treatment
treatment strategy
Trial
virus
[DOI] 10.3389/fmed.2021.604087 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.604087 PMC 바로가기 [Article Type] Medicine